1. Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies. (9th March 2022) Authors: Calisti, Fabrizio; Cattaneo, Agnese; Calabrese, Mariangela; Mao, Yongcai; Tocco, Michael; Pikalov, Andrei; Goldman, Robert Journal: International clinical psychopharmacology Issue: Volume 37:Number 5(2022) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗